Insights on the Smart Inhalers Global Market to 2025 – Competitive Analysis and the Impact of COVID-19 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Smart Inhalers Market (2020-2025) by Components, Product, Application, Distribution Channel, End-Use, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global Smart Inhalers Market is estimated to be USD 118.35 Mn in 2020 and is expected to reach USD 257.38 Mn by 2025, growing at a CAGR of 16.81%.

Key factors such as growth in respiratory disorders such as asthma and Chronic Obstructive Pulmonary Diseases (COPD) and growing acceptance towards digital healthcare equipment have driven the demand for the smart inhaler market. Similarly, the demand for real-time monitoring devices in the healthcare sector has additionally supported the growth of the market further.

However, the high cost of smart inhalers and the evident presence and utilization of manual inhalers poses to be a restraining factor to the growth of the market.

Companies Mentioned

• OPKO Health, Inc.
• AstraZeneca plc
• GlaxoSmithKline
• Propeller Health (ResMed Inc)
• Aptar Pharma
• Novartis AG
• Boehringer Ingelheim
• Teva Pharmaceuticals
• H&T Presspart Manufacturing Ltd.
• Sensirion AG
• Cohero Health, Inc (AptarGroup Inc)
• Adherium Limited
• Gecko Health Innovations, Inc (Teva Pharmaceuticals)
• Agilent Technologies
• 3M Medical
• Inspiro Medical (OPKO Health Inc)
• Findair Sp. z o. o.
• Vectura Group
• Zeolr Technologies Pvt Ltd.
• ResMed, Inc.

Recent Developments
1. AptarGroup, Inc has partnered with Sonmol for developing connected drug delivery devices, digital therapies, and services platform for respiratory and other diseases – 21st April 2020

2. Teva Pharmaceuticals has got its 3rd Digi inhaler approved known as the ArmonAir Digihaler monotherapy maintenance treatment. It is considered the first-gen medicine-only dispenser. – 11th March 2020

Why buy this report?

• The report offers a comprehensive evaluation of the Global Smart Inhalers Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
• The report also contains the competitive analysis using IGR Positioning Quadrants, the analyst’s proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Overview
4.1 Introduction

4.2 Market Dynamics

4.2.1 Drivers

4.2.1.1 Rising prevalence of respiratory-related disorders

4.2.1.2 Growth in real-time monitoring devices

4.2.1.3 Rising acceptance towards digital healthcare equipment

4.2.2 Restraints

4.2.2.1 High price of the smart inhalers

4.2.2.2 Presence of manual inhalers

4.2.3 Opportunities

4.2.3.1 Technological Advancements

4.2.3.2 Growing collaborations between smart inhaler manufacturers and software companies

4.2.4 Challenges

4.2.4.1 Limited product availability in emerging markets

4.3 Trends

5 Market Analysis
5.1 Porter’s Five Forces Analysis

5.2 Impact of COVID-19

5.3 Ansoff Matrix Analysis

6 Global Smart Inhalers Market, By Component
6.1 Introduction

6.2 Solutions

6.3 Services

7 Global Smart Inhalers Market, By Product
7.1 Introduction

7.2 Inhalers

7.2.1 Dry Powder Inhaler

7.2.2 Metered-Dose Inhaler

7.3 Nebulizer

8 Global Smart Inhalers Market, By Application
8.1 Introduction

8.2 Asthma

8.3 COPD

9 Global Smart Inhalers Market, By Distribution channel
9.1 Introduction

9.2 Hospitals Pharmacies

9.3 Retail Pharmacies

9.4 Online channel

10 Global Smart Inhalers Market, By End Use
10.1 Introduction

10.2 Patients

10.3 R&D

10.4 Others

11 Global Smart Inhalers Market, By Geography
11.1 Introduction

11.2 North America

11.2.1 US

11.2.2 Canada

11.2.3 Mexico

11.3 South America

11.3.1 Brazil

11.3.2 Argentina

11.4 Europe

11.4.1 UK

11.4.2 France

11.4.3 Germany

11.4.4 Italy

11.4.5 Spain

11.4.6 Rest of Europe

11.5 Asia-Pacific

11.5.1 China

11.5.2 Japan

11.5.3 India

11.5.4 Indonesia

11.5.5 Malaysia

11.5.6 South Korea

11.5.7 Australia

11.5.8 Russia

11.5.9 Rest of APAC

11.6 Rest of the World

11.6.1 Qatar

11.6.2 Saudi Arabia

11.6.3 South Africa

11.6.4 United Arab Emirates

11.6.5 Latin America

12 Competitive Landscape
12.1 Competitive Quadrant

12.2 Market Share Analysis

12.3 Competitive Scenario

12.3.1 Mergers & Acquisitions

12.3.2 Agreement, Collaborations, & Partnerships

12.3.3 New Product Launches & Enhancements

12.3.4 Investments & Funding

13 Company Profiles

14 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/af3i4k

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900